Evidence map›Paper›PMID 25691884›Full record

ArticleFrontiers in immunology2015

Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection.

Edward J Farnell, Nidhi Tyagi, Stephanie Ryan, Iain W Chalmers, Angela Pinot de Moira, Frances M Jones, Jakub Wawrzyniak, Colin M Fitzsimmons, Edridah M Tukahebwa, Nicholas Furnham and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Dermatology reports · 2024
    Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Edward J FarnellDepartment of Pathology, University of Cambridge , Cambridge , UK.
Nidhi TyagiEuropean Bioinformatics Institute , Cambridge , UK.
Stephanie RyanInstitute of Immunology and Infection Research, The University of Edinburgh , Edinburgh , UK.
Iain W ChalmersInstitute of Biological, Environmental and Rural Sciences, Aberystwyth University , Aberystwyth , UK.
Angela Pinot de MoiraDepartment of Pathology, University of Cambridge , Cambridge , UK.
Frances M JonesDepartment of Pathology, University of Cambridge , Cambridge , UK.
Jakub WawrzyniakDepartment of Pathology, University of Cambridge , Cambridge , UK.
Colin M FitzsimmonsDepartment of Pathology, University of Cambridge , Cambridge , UK.
Edridah M TukahebwaVector Control Division, Ugandan Ministry of Health , Kampala , Uganda.
Nicholas FurnhamEuropean Bioinformatics Institute , Cambridge , UK ; Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine , London , UK.
Rick M MaizelsInstitute of Immunology and Infection Research, The University of Edinburgh , Edinburgh , UK.
David W DunneDepartment of Pathology, University of Cambridge , Cambridge , UK.
University of Cambridge · GBUniversity of Edinburgh · GBAberystwyth University · GBEuropean Bioinformatics Institute · GBMinistry of Health · UGUniversity of London · GB

Funding

Medical Research Council MR/K020420/1Wellcome Trust 095831Wellcome Trust 106122
6 · The paper itself

Abstract

The IgE response has been associated with both allergic reactions and immunity to metazoan parasites. Recently, we hypothesized that all environmental allergens bear structural homology to IgE-binding antigens from metazoan parasites and that this homology defines the relatively small number of protein families containing allergenic targets. In this study, known allergen structures (Pfam domains) from major environmental allergen families were used to predict allergen-like (SmProfilin, SmVAL-6, SmLipocalin, SmHSP20, Sm triosephosphate isomerase, SmThioredoxin, Sm superoxide dismutase, SmCyclophilin, and Sm phosphoglycerate kinase) and non-allergen-like [Sm dynein light chain (SmDLC), SmAldolase SmAK, SmUbiquitin, and Sm14-3-3] proteins in Schistosoma mansoni. Recombinant antigens were produced in Escherichia coli and IgG1, IgG4, and IgE responses against them measured in a cohort of people (n = 222) infected with S. mansoni. All allergen-like antigens were targeted by IgE responses in infected subjects, whilst IgE responses to the non-allergen-like antigens, SmAK, SmUbiquitin, and Sm14-3-3 were essentially absent being of both low prevalence and magnitude. Two new IgE-binding Pfam domain families, not previously described in allergen family databases, were also found, with prevalent IgE responses against SmDLC (PF01221) and SmAldolase (PF00274). Finally, it was demonstrated that immunoregulatory serological processes typically associated with allergens also occurred in responses to allergen-like proteins in S. mansoni infections, including the production of IgG4 in people responding with IgE and the down-regulation of IgE in response to increased antigen exposure from S. mansoni eggs. This study establishes that structures of known allergens can be used to predict IgE responses against homologous parasite allergen-like molecules (parallergens) and that serological responses with IgE/IgG4 to parallergens mirror those seen against allergens, supporting our hypothesis that allergenicity is rooted in expression of certain protein domain families in metazoan parasites.

Indexed as

allergenicityhelminth proteinsIgEIgG4metazoan parasiteparasite allergensschistosomiasis mansoni

Identifiers

PMID25691884
PMCPMC4315118
OpenAlexW2084349928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.